APA

Chambers M. S., Street L. J., Goodacre S., Hobbs S. C., Hunt P., Jelley R. A., Matassa V. G., Reeve A. J., Sternfeld F., Beer M. S., Stanton J. A., Rathbone D., Watt A. P. & MacLeod A. M. (19990316). 3-(Piperazinylpropyl)indoles: selective, orally bioavailable h5-HT1D receptor agonists as potential antimigraine agents. : Journal of medicinal chemistry.

Chicago

Chambers M S, Street L J, Goodacre S, Hobbs S C, Hunt P, Jelley R A, Matassa V G, Reeve A J, Sternfeld F, Beer M S, Stanton J A, Rathbone D, Watt A P and MacLeod A M. 19990316. 3-(Piperazinylpropyl)indoles: selective, orally bioavailable h5-HT1D receptor agonists as potential antimigraine agents. : Journal of medicinal chemistry.

Harvard

Chambers M. S., Street L. J., Goodacre S., Hobbs S. C., Hunt P., Jelley R. A., Matassa V. G., Reeve A. J., Sternfeld F., Beer M. S., Stanton J. A., Rathbone D., Watt A. P. and MacLeod A. M. (19990316). 3-(Piperazinylpropyl)indoles: selective, orally bioavailable h5-HT1D receptor agonists as potential antimigraine agents. : Journal of medicinal chemistry.

MLA

Chambers M S, Street L J, Goodacre S, Hobbs S C, Hunt P, Jelley R A, Matassa V G, Reeve A J, Sternfeld F, Beer M S, Stanton J A, Rathbone D, Watt A P and MacLeod A M. 3-(Piperazinylpropyl)indoles: selective, orally bioavailable h5-HT1D receptor agonists as potential antimigraine agents. : Journal of medicinal chemistry. 19990316.